These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3955840)

  • 1. Prenatal diagnosis of GM2 gangliosidoses using a fluorogenic sulfated substrate.
    Inui K; Wenger DA; Furukawa M; Suehara N; Yutaka Y; Okada S; Tanizawa O; Yabuuchi H
    Clin Chim Acta; 1986 Jan; 154(2):145-50. PubMed ID: 3955840
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified method for prenatal diagnosis of Tay-Sachs disease in cell-free amniotic fluid.
    Navon R; Wiselter J; Modan M
    Monogr Hum Genet; 1978; 9():186-92. PubMed ID: 732839
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal diagnosis of Tay-Sachs disease in cell-free amniotic fluid.
    Christomanou H; Cáp C; Sandhoff K
    Klin Wochenschr; 1978 Nov; 56(22):1133-5. PubMed ID: 713433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microtechniques for the detection of lysosomal enzyme disorders: Tay-Sachs disease, Gm1-gangliosidosis and Fabry disease.
    Bladon MT; Milunsky A
    Clin Genet; 1978 Dec; 14(6):359-66. PubMed ID: 215359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.
    Kaur M; Verma IC
    Indian J Pediatr; 1995; 62(4):485-9. PubMed ID: 10829910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of homozygotes and heterozygote carriers of GM2-gangliosidosis].
    Aronovich EL; Krasnopol'skaia KD; Kukharenko VI; Pichugina EM
    Genetika; 1986 Aug; 22(8):2179-85. PubMed ID: 3770476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 4-methylumbelliferyl-6-sulpho-2-acetamido-2-deoxy-beta- D-glucopyranoside for prenatal diagnosis of Tay-Sachs disease using chorionic villi.
    Grebner EE; Wenger DA
    Prenat Diagn; 1987 Jul; 7(6):419-23. PubMed ID: 2958791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of Tay-Sachs disease with heat-labile beta-hexosaminidase B.
    Momoi T; Kikuchi K; Shigematsu Y; Sudo M; Tanioka K
    Clin Chim Acta; 1983 Oct; 133(3):331-4. PubMed ID: 6226459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prenatal diagnosis of hereditary lysosomal diseases].
    Mirenburg TV; Aronovich EL; Lebedeva TV; Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1988; 34(4):41-6. PubMed ID: 3143186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis for Tay-Sachs disease using chorionic villus sampling.
    Grebner EE; Jackson LG
    Prenat Diagn; 1985; 5(5):313-20. PubMed ID: 2933645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of Tay-Sachs disease: studies on the reliability of hexosaminidase levels in amniotic fluid.
    Grebner EE; Jackson LG
    Am J Obstet Gynecol; 1979 Jul; 134(5):547-50. PubMed ID: 453293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon.
    Der Kaloustian VM; Khoury MJ; Hallal R; Idriss ZH; Deeb ME; Wakid NW; Haddad FS
    Am J Hum Genet; 1981 Jan; 33(1):85-9. PubMed ID: 7468596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gangliosidosis GM2 type 2 (Sandhoff disease)].
    Sánchez-Corona J; Vaca G; González-Flores SA; Villar V; Solé MT; Barajas LO; Velázquez R; Valdez-Luviano J; Cantú JM
    Rev Invest Clin; 1985; 37(1):43-7. PubMed ID: 4001618
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.
    Kissell J; Rochmann C; Minini P; Eichler F; Stephen CD; Lau H; Toro C; Johnston JM; Krupnick R; Hamed A; Cox GF
    Mol Genet Metab; 2024 Jul; 142(3):108512. PubMed ID: 38870773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of atypical Tay-Sachs disease by chorionic villi sampling.
    Besançon AM; Belon JP; Castelnau L; Dumez Y; Poenaru L
    Prenat Diagn; 1984; 4(5):365-70. PubMed ID: 6504850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of glycosidases in amniotic fluid cell cultures].
    Tsvetkova IV; Zolotukhina TV; Rozenfel'd EL; Rozovskiĭ IS
    Vopr Med Khim; 1979; 25(2):214-8. PubMed ID: 442593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GM2 gangliosidosis--Tay-Sacks disease and Sandhoff's disease].
    Okada S
    Nihon Rinsho; 1978 May; Suppl():1394-5. PubMed ID: 691367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prenatal diagnosis of Tay-Sachs disease].
    Zoltán P; Piroska B; Károly C
    Orv Hetil; 1975 Sep; 116(39):2305-7. PubMed ID: 1187112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.